Thomas Winker

January 17, 2025

Thomas Winkler joined Fulcrum in September 2024 from Cimeio Therapeutics, where he served as Chief Medical Officer. Thomas is responsible for our hematology program and for the PIONEER study for pociredir. Previously, Thomas served in the hematology branch of the NIH before transitioning to industry, where his work focused on developing numerous hematology programs at Agios Pharmaceuticals and AstraZeneca.

Thomas holds a Doctor of Medicine from Medizinische Hochschule Hannover.